Jonathan Wosen, Ph.D.

Hey folks! A friendly note that you can find me on Bluesky (@jonathanwosen.bsky.social). I'll for now continue to post here on X, but that may wind down with time. I also routinely share stories via LinkedIn: linkedin.com/in/jonathan-wo…

The FDA and NIH are moving away from animal testing, but do researchers think that's a good idea? @AAASMassMedia Fellow @marissarussoo and I spoke with 10+ researchers across academia and biotech to find out. Story via @statnews. statnews.com/2025/07/25/nih…

Why Sarepta may not survive its current gene therapy crisis. Plus: Who gets to decide the CEO’s fate? statnews.com/2025/07/24/sar…

An inside look at how University of Minnesota president grapples with massive cuts in federal funding By @JonathanWosen statnews.com/2025/07/21/uni… via @statnews @UMNews

Peter Marks, the FDA official who overruled his own staff to approve Sarepta's Duchenne gene therapy, told STAT he agreed with the decision to pause shipments after recent deaths. “It does seem like it makes a fair amount of sense to get a better handle on the issues before…

Now official and then some... Sarepta Therapeutics $SRPT lays off one-third of workforce in drastic cost-cutting move statnews.com/2025/07/16/sar… w/ @Jasonmmast

HHS efficiency review blamed for delaying patient care at Indian Health Service. Excellent reporting via @angRchen for @statnews statnews.com/2025/07/15/ind…

Ozempic for addiction: How an elite rehab center is using GLP-1s to ‘obliterate’ all kinds of cravings statnews.com/2025/07/14/glp… via Lev Facher for @statnews

Researchers have been sneaking secret messages into their papers in an effort to trick AI tools into giving them a positive peer-review report, writes @LizzieGibney for @Nature nature.com/articles/d4158…

FDA rejects Capricor’s $CAPR cell therapy for Duchenne muscular dystrophy The FDA decision follows the ouster of the agency’s chief regulator of cell and gene therapies statnews.com/2025/07/11/fda…

Scoop from @JonathanWosen - Academic groups finalize counterproposal to NIH research overhead cuts statnews.com/2025/07/10/aca… via @statnews

The California Institute for Regenerative Medicine owns a stem cell biobank that was once the largest of its kind in the world. It's now racing to sell off thousands of samples before many of them are discarded. My latest for @statnews statnews.com/2025/07/11/ste…

A coalition of academic groups has finalized a counterproposal to Trump’s research overhead cuts. This @statnews exclusive came from my continued efforts to track the battle over indirect costs. statnews.com/2025/07/10/aca…

Some razzle dazzle from the FDA this morning, as it suggests a big reveal that ends up being a little less than that. Story via @DrewQJoseph statnews.com/2025/07/10/fda…

Wait.. BIG caveat. These CRL letters are for drugs that were later approved. The really good stuff -- CRLs for drugs not/never approved are not being disclosed.

Breaking: HHS Secretary RFK Jr. has abruptly cancelled a meeting of the advisory committee that evaluates the nation's preventative services. No reason was provided via a letter viewed by STAT. statnews.com/2025/07/09/usp…

The United States has now recorded more confirmed measles cases this year than in any year in well over a quarter-century — and 2025 is only just past the halfway mark, @HelenBranswell writes for @statnews statnews.com/2025/07/09/mea…

As a cancer patient, access to innovative drugs can help extend your life — that is, if you have health insurance, a new study finds. Story via @AAASMassMedia Fellow @marissarussoo for @statnews statnews.com/2025/07/07/can… via @statnews

How the GOP, behind closed doors, pushed through health industry fears and passed historic Medicaid cuts statnews.com/2025/07/08/tru…

Exclusive: I spoke with 15 employees at the FDA to get a sense of how the agency is functioning since the April 1 layoffs. They described tanking morale and an intensifying staff exodus. Read more here: statnews.com/2025/07/07/fda…

Cogent Biosciences $COGT drug improves symptoms of chronic immune disorder, study results show A comparison of the therapy to a rival treatment from Blueprint Medicines $BPMC remains muddled statnews.com/2025/07/07/cog…